Most Popular Stories
- Ben Venue can't say when crucial cancer drug will be available
- Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
- Ben Venue's idled plant triggers 'dire' leukemia-drug shortage
- The best of times, the worst of times?
- Pioneering stem cell therapy mends damaged heart tissue in patients
- Novartis dealt another setback to broader Menveo use
- InnaVirVax nabs $4.9M in B round to advance HIV immunotherapy
- Actelion hunts for answers about 120 deaths in key drug trial
- Pfizer R&D chief talks up chances for late-stage Alzheimer's drug
- Karo Bio walks away from Phase III cholesterol drug due to safety risks
- Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
Webinars
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
Featured Jobs
-
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA -
Director Marketing Communications
Bailey Search & Associates - Boston, MA -
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US
Events
- Connect, Collaborate, & Innovate: MassBio Annual Meeting
March 26-27 — Cambridge, MA - BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida - Just Released: New Trends in Preventive and Therapeutic Vaccine
- Pharmaceutical Strategic Outlook
April 11-13, 2012
Related Topics >> Biotech CEO
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- The Cutting Edge of Chemistry
- Pharma 2.0: Heading Toward Social Media Marketing
- Role of Micro Blogging in Search Engine Marketing
- Retaining Brand Loyalty
- New MicroMass Study of Social Media Behavior Offers Connection Planning Insights for Healthcare Marketers
- Niche Tourism Beginning and digital marketing : Beginning of the future?
Diane Goostree, Former Artes Medical CEO
